Selecting a service provider is a pivotal decision for any company. In the biopharmaceutical sector, this choice holds immense significance as it impacts the journey of life-saving treatments from discovery to commercialization. Biopharmaceutical innovators, working on a global scale, frequently collaborate with external entities, including contract development and manufacturing organizations (CDMOs), to support their manufacturing requirements.
As the landscape of drug manufacturing continuously evolves, Industry Standard Research (ISR) has been conducting annual CDMO benchmarking research to capture its dynamic nature. This eBook delves into the insights derived from ISR's primary market research, shedding light on the latest trends in sponsor outsourcing behavior.
In several articles throughout the report, authors share insights on key attributes sponsors should look for in a provider across four manufacturing areas, trends in the biologic API manufacturing sector, changes in selection attributes' importance and their role in the CMO Leadership Awards, as well as the impact of the COVID-19 pandemic on small molecule and biologic drug product manufacturing.
Access the eBook below to unearth how ISR's research is empowering decision-makers while helping CDMOs tailor their strategies to better meet sponsor needs through reliable benchmark data, grounded in rigorous methodology.